2022 Medtech Leaders Agenda

Day One | Day Two

Tuesday, June 21 - Medtech Leaders
(All times in EDT)

9:15am Chair’s opening remarks

9:25am Capitalising on Medtech opportunities post Covid: the current upsurge and necessity of innovation, product development and business opportunities and how it is changing the investment landscape

During the pandemic years there was a scarcity of Medtech deals and with backlog of procedures due to the deferral of non-emergency procedures, 2022 onwards is set for a hype of activity. A panel of Medtech companies and stakeholders involved in recent mergers or acquisitions discuss:

• The challenges and drivers of the current M&A landscape
  
• Has innovation across product design led to new collaborations and deals from Medtech leaders
  
• What are the most significant challenges Medtech innovators encounter on the way to acquisition—where are the crucial inflection points in the journey?
  
• How has trend towards more large consolidations impacted innovators ready to be acquired?

Moderator: Jonathan Gertler, Managing Parter & CEO, Back Bay Life Science Advisors BioVentures Medtech Funds
Richard Wilmot, Head of Philips Venture Investments, Phillips
Christopher Cleary, VP Corporate Development, Medtronic
Laura Niklason, CEO, Humacyte
Townsend Goddard, Senior VP of Global Business Development, Olympus

10:05am Successful partnering between Medtech Leaders and Providers: navigating commercial success by securing the right partner at the right time

The healthcare infrastructure is under considerable strain which has resulted in changes in solution requirements and budgets. Healthcare providers are seeking cost effective and easy-to-implement products from the Medtech sector as well as new digital and supportive services. This panel will discuss how Medtech leaders are not only positioning themselves to deliver healthcare provision but also develop strategic partnerships to streamline the process. Hear which Medtech solutions are crucial to US healthcare systems and learn what opportunities leading medical device players are looking for emerging companies to bring to the table.

Moderator: Martin Kelleher, Corporate Partner and Head of the Life Sciences Team, Mason Hayes & Curran
Antonio Sanchez-Cordero, VP Business Development (M&A) Peripheral Intervention, BD
Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive Surgical
Matthew Savary, Innovation Fund & New Ventures Principal – Medtech, UCLA Technology Development Group

          

10:45am Coffee break and refreshments

11:15am Investing in all MedTech: forensic review the investment interests, landscape, opportunities across medical devices, connected medical products and digital services

Medtech is ripe for growth following increasing globally revenue of over $500 billion annually and the need for patient-centric products in healthcare. New business opportunities are emerging, particularly in digital products and robotics, but with the more established companies securing the lioon’s share of investment, and market access regulatory legislation for new players unclear, where and why are investors placing their bets for this growing market?

Moderator: Katy Gardner, Partner, Brown Rudnick
Oliver Keown, Managing Director, Intuitive Ventures
Debbie Lin, Executive in Residence, DigitalDx; Former Pharma Corporate Venture Investment Executive
Lori Hu, Managing Director, Vertex Ventures
Jeffrey Schwartz, Managing Director, Bain Capital

              

11:55am The digital age of Medtech

Digital innovation has seen vast growth across healthcare where digital and data solutions can be applied to many medical devices’ verticals including diagnostics and surgical equipment. A panel of experts will discuss digital innovation, investment and adoption across the Medtech industry:

• How can you utilise digital solutions to make patient centric products in MedTech
  
• Consideration of digital adoption and timelines and while taking full advantage of market growth potential
  
• What investment practices are backing the integration of digital and data within MedTech
  
• Addressing the gaps in medical devices with digital offerings, how can traditional medical devices and digital connected medical devices evolve together

Moderator: Jennifer Fried, Co-Founder & CEO, Explorer Surgical
Deanna Harshbarger, VP Product, Cala Health
Thomas Hummel, Digital Transformation Corporate Development, Fresenius Kabi
David Nace, Chief Medical Officer, Innovaccer

12:35pm Value based Healthcare expansion with Real World Evidence/Data

There is continued pressure from payers on the importance of demonstrating capabilities through RWE/RWD to show how innovations will provide overall value to health systems. Those who can will be the winners in an increasingly competitive market improved market. A panel of experts will discuss the creation and expansion opportunities of value-based healthcare within the MedTech:

• How is market growing around RWE/RWD and impacting value-based healthcare
  
• Necessity of improved data accumulation and clinical trial management
  
• The opportunity and requirement new funding and payment models, and markets parallel with healthcare for medical devices

Moderator: Rowan Walrath, Life Sciences Reporter, Boston Business Journal
Claire Woodthorpe, VP Europe, Chief Operating Officer, Light Point Medical
Simon Blanc, Medical Director, IntegraConnect
Giles Hamilton, Chief Executive Officer, ODx Innovations

1:15pm Lunch

2:30pm MassMakes – Conditions for a Competitive and Secure Future

Ben Linville-Engler, Chief Investment Strategist and Program Executive, MassTech

2:45pm Medtech Partnering Presentation

2:55pm Medtech Partnering Presentation

Saurabh Bhasin, Vice President of M&A, Fresenius Kabi

3:15pm Coffee break and refreshments

4:00pm Regulatory Medical Device Hurdles: How to overcome challenges, de-risk development and advance new technologies for Women Health products

• Regulatory oversights and the challenges with new products within medical devices for reproductive health
  
• Insights into advancing FemaSeed and FemBloc to lead clinical-stage products
  
• How to de-risk product development to secure scaling investment

Kathy Lee-Sepsick, President & Chief Executive Officer, Femasys

4:30pm Panel: Mapping Medtech Market Access: Understanding the dynamics between provider, patient and product for market entry

Point of care and patient centric products are growing in demand. While this has always been at the heart of healthcare, patients are now looking to be more involved in their healthcare and the healthcare industry across the US is also looking for patients to adopt evermore new products and innovations to relieve healthcare system pressure. But, in practice, how easily are these solutions being implemented and how are medtech players working with providers to develop the right market access play?

• Understanding how the adoption journey differs depending on geographical market
  
• Navigating local and national market access routes to benefit providers, payers and patients

Moderator: Jonathan Pappas, Vice President, LifeSci Communications
Bob Bargenquast, Head of U.S. Market Access Strategy & Reimbursement, Zeiss
Shani Noel, Director, Market Access & Managed Care, Respiratory Health, Baxter
Maria Shepherd, President, Medi-Vantage
Amanda Briscoe, SVP, Business Development, Veranex Solutions

5:20pm Close of Day 1

5:30pm Networking Drinks Reception

The networking drinks reception takes place Tuesday, June 21. Attendees can look forward to a fantastic night of networking and double down on their event relationship building.

Wednesday, June 22 - Break out sessions
(All times in EDT)

9:15am MedTech CEO Forum

Open to CEO, Founder, Co-Founder, President, Chairman or or c-suite executives (CFO, CBO, CCO, CSO, CMO) of US and Medtech companies.

Free to attend, pre-registration only, Chatham House Rule forum where all participants are active discussants. 

Please sign-up during registration.

Find out more